Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00813865 · ClinicalTrials.gov registry record · Phase 2
A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients
A Phase 2 study, sponsored by Amicus Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT00813865 is a Phase 2 study that has completed, run by Amicus Therapeutics. The registered enrollment target is 8 participants.
The verdict
NCT00813865, a Phase 2 study, has completed, sponsored by Amicus Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study evaluated the long-term safety and efficacy of afegostat tartrate in participants with Gaucher disease who were enrolled in a previous Phase 2 study of afegostat tartrate.
Interventions
- DRUG afegostat tartrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2009-05-11 |
| Est. Completion | 2012-05-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00813865
The ClinicalTrials.gov registry entry for NCT00813865 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amicus Therapeutics, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which afegostat tartrate is the first listed.
NCT00813865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00813865 about?
NCT00813865 is a clinical study titled "A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients". This study evaluated the long-term safety and efficacy of afegostat tartrate in participants with Gaucher disease who were enrolled in a previous Phase 2 study of afegostat tartrate.
What is the current status of trial NCT00813865?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2009-05-11. Estimated completion is 2012-05-01.
What interventions are being tested in trial NCT00813865?
The interventions under investigation include: afegostat tartrate (DRUG).
Who is sponsoring clinical trial NCT00813865?
This trial is sponsored by Amicus Therapeutics, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.